Search results for "INSULIN"

showing 10 items of 1360 documents

Effect of insulin on readmission for heart failure following a hospitalization for acute heart failure

2020

AIMS: Type 2 diabetes mellitus (T2DM) is common in patients with heart failure (HF) and is related with worse outcomes. Insulin treatment is associated with sodium and water retention, weight gain, and hypoglycaemia-all pathophysiological mechanisms related to HF decompensation. This study aimed to evaluate the association between insulin treatment and the risk of 1year readmission for HF in patients discharged for acute HF.; METHODS AND RESULTS: We prospectively included 2895 consecutive patients discharged after an episode of acute HF in a single tertiary hospital. Multivariable Cox regression, adapted for competing events, was used to assess the association between insulin treatment and …

medicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineInternal medicineDiabetes mellitusOriginal Research ArticlesType 2 diabetes mellitusmedicineDiseases of the circulatory (Cardiovascular) systemDecompensation030212 general & internal medicineOriginal Research ArticleEjection fractionbusiness.industryProportional hazards modelInsulinHazard ratioType 2 Diabetes MellitusAcute heart failureHospital readmissionmedicine.diseaseHeart failureRC666-701Insulin therapyCardiology and Cardiovascular Medicinebusiness
researchProduct

Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells.

1996

In this study, we have demonstrated that human retinoblastoma Y79 cells produce insulin-like growth factors (IGFs) type I and type II and release them into the medium. We have also ascertained, by means of competitive studies and cross-linking procedure, that Y79 cells contain the type-I IGF receptor (IGF-IR). Furthermore, surface-bound IGF-I is internalised by the receptor, then degraded to amino acids. Insulin, IGF-I and IGF-II caused down-regulation of IGF-IR; the effect is concentration and time dependant. Scatchard analysis demonstrated that incubation with insulin markedly decreased the binding capacity measured for IGF-I while the apparent Kd value calculated for IGF-I binding was no…

medicine.medical_specialtymedicine.medical_treatmentBiologyBiochemistryBinding CompetitiveReceptor IGF Type 1chemistry.chemical_compoundInsulin-Like Growth Factor IIInternal medicineInsulin receptor substratemedicineHumansInsulinInsulin-Like Growth Factor IAutocrine signallingPhosphotyrosineInsulin-like growth factor 1 receptorInsulinRetinoblastomaTyrosine phosphorylationPhosphoproteinsIRS2Insulin receptorautocrine growthEndocrinologychemistrybiology.proteinInsulin Receptor Substrate ProteinsPlatelet-derived growth factor receptorCell DivisionSignal TransductionEuropean journal of biochemistry
researchProduct

Hyperinsulinemia, hyperproinsulinemia and insulin resistance in the metabolic syndrome.

1996

For better comprehension of the metabolic syndrome, it is necessary to differentiate the effect of insulin on glucose metabolism on the one hand, and on other metabolic activities on the other hand. Whereas glucose utilization is affected by insulin resistance, the effect of insulin on lipid metabolism, ion and aminoacid transport does not seem to be diminished. Lipid metabolism, however, seems to play a crucial role in the induction of the vicious cycle. Increased energy and fat ingestion may be due to an increased number of galanin secreting cells in the hypothalamus. The excessive fat intake results in an increased rate of release of insulin and increased influx of triglycerides into the…

medicine.medical_specialtymedicine.medical_treatmentCarbohydrate metabolismFatty Acids NonesterifiedHyperproinsulinemiaModels BiologicalCellular and Molecular NeuroscienceInsulin resistanceInternal medicineHyperinsulinismmedicineHyperinsulinemiaAnimalsHomeostasisHumansInsulinMolecular BiologyTriglyceridesPharmacologyChemistryInsulinCell BiologySyndromemedicine.diseaseEndocrinologyAminoacid transportMolecular MedicineMetabolic syndromeInsulin ResistanceHyperinsulinismProinsulinExperientia
researchProduct

Metabolic response to 6-week aerobic exercise training and dieting in previously sedentary overweight and obese pre-menopausal women: A randomized tr…

2014

AbstractBackground: The aim of this study was to compare 6 weeks short-term moderate intensity aerobic exercise and dieting on serum metabolomicsand cardio-metabolic risk factors in pre-menopausal women.Methods: Ninety previously inactive overweight and obese (BMI 25e35 kg/m 2 ) women (age 41.5 7.6 years) were randomized to either a6-week Nordic walking exercise program (EX, n ¼ 45) or dietary counseling group (DI, n ¼ 45). Body composition, serum glucose, insulin andlipids were measured. Serum low-molecular-weight metabolites and lipid constituents were analyzed by nuclear magnetic resonance spec-troscopy. Measurements were done at baseline and 7 days after the last training session.Result…

medicine.medical_specialtymedicine.medical_treatmentDietingPhysical Therapy Sports Therapy and RehabilitationOverweightlaw.inventionlcsh:GV557-1198.995Insulin resistanceRandomized controlled trialWeight losslawInternal medicinemedicineMetabolomicsAerobic exerciseWomenOrthopedics and Sports Medicinelcsh:Sports medicineExerciselcsh:Sportsbusiness.industryInsulinta3141Metabolismmedicine.diseaseMetabolismEndocrinologymedicine.symptomlcsh:RC1200-1245businessDietingJournal of Sport and Health Science
researchProduct

Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X

2003

Magnesium (Mg) is one of the most abundant ions present in living cells and its plasma concentration is remarkably constant in healthy subjects. Plasma and intracellular Mg concentrations are tightly regulated by several factors. Among them, insulin seems to be one of the most important. In vitro and in vivo studies have demonstrated that insulin may modulate the shift of Mg from extracellular to intracellular space. Intracellular Mg concentration has also been shown to be effective in modulating insulin action (mainly oxidative glucose metabolism), offset calcium-related excitation-contraction coupling, and decrease smooth cell responsiveness to depolarizing stimuli. A poor intracellular M…

medicine.medical_specialtymedicine.medical_treatmentGlucose uptakeClinical BiochemistryBiologyCarbohydrate metabolismBiochemistryInsulin resistanceDiabetes mellitusInternal medicinemedicineHumansInsulinMagnesiumMolecular BiologyMetabolic SyndromeInsulinGeneral Medicinemedicine.diseaseOxidative StressInsulin receptorEndocrinologyDiabetes Mellitus Type 2Hypertensionbiology.proteinMolecular MedicineInsulin ResistanceVanadatesMetabolic syndromeIntracellularMolecular Aspects of Medicine
researchProduct

Effects of dietary conjugated linoleic acids in the control of adiposity and obesity‐related disorders

2007

The body fat-lowering effect of conjugated linoleic acids (CLA) in experimental animals has attracted much interest because of the potential use of CLA as weight loss agents in humans. The objective of this review was to give an overview of the results from human intervention trials. The review also addresses experimental studies in animal models and in cultured cells. CLA appear to provoke fat mass loss and an increase of fat-free mass in rodents, but the results in humans are inconsistent and much less clear than in rodents. Thus, the results of studies in humans do not support a body fat-lowering effect of CLA. There are indications from animal studies that the trans-10, cis-12 CLA isome…

medicine.medical_specialtymedicine.medical_treatmentLinoleic acidConjugated linoleic acidBiologyIndustrial and Manufacturing Engineeringchemistry.chemical_compoundInsulin resistanceLiver steatosisInternal medicinemedicinechemistry.chemical_classificationintegumentary systemInsulinfood and beveragesGeneral Chemistrymedicine.diseaseObesityEndocrinologyBiochemistrychemistrylipids (amino acids peptides and proteins)Animal studiesFood ScienceBiotechnologyPolyunsaturated fatty acidEuropean Journal of Lipid Science and Technology
researchProduct

Successful Control of Hypoglycemia with Pasireotide LAR in a Patient with Inappropriate Insulin Secretion

2021

Introduction Inappropriate insulin secretion could be due to several diseases. Nesidioblastosis is characterized by diffuse hyperplasia of pancreatic beta cells, causing organic hypoglycemia. No pancreatic lesions are found on the imaging of patients with this condition. Diazoxide is used as a first-line treatment but can be poorly tolerated because of its side effects, and therapeutic failure is possible. Somatostatin analogues have limited efficacy because of their poor affinity to somatostatin (SST) receptors. Pasireotide is a somatostatin analogue with a much higher affinity to SST receptors, especially SST5, and it could thus be more efficient for treating nesidioblastosis-related hypo…

medicine.medical_specialtymedicine.medical_treatmentNesidioblastosisOctreotideCase ReportHypoglycemiaGastroenterologychemistry.chemical_compoundInternal medicinemedicineDiazoxidePharmacology (medical)business.industryInsulinnutritional and metabolic diseasesmedicine.diseasenesidioblastosisPasireotidediazoxideSomatostatinhypoglycemiachemistrySitagliptinpasireotide LARbusinessmedicine.drugClinical Pharmacology : Advances and Applications
researchProduct

Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients.

2011

Diabetes is associated with oxidative stress. This study evaluated the rates of oxidative stress and mitochondrial impairment in type 2 diabetes patients. The study population consisted of 182 diabetic patients and 50 body-composition- and age-matched controls. We assessed anthropometric and metabolic parameters and mitochondrial function by evaluating mitochondrial oxygen (O2) consumption, reactive oxygen species (ROS) production, glutathione (GSH) levels, GSH/GSSG ratio, mitochondrial membrane potential, and mitochondrial complex I activity in polymorphonuclear cells from diabetes type 2 patients. We found an increase in waist circumference and augmented serum levels of triglycerides, pro…

medicine.medical_specialtymedicine.medical_treatmentType 2 diabetesMitochondrionBiologymedicine.disease_causeBiochemistryArticlechemistry.chemical_compoundInsulin resistancePhysiology (medical)Internal medicineDiabetes mellitusRotenonemedicineLeukocytesHumanschemistry.chemical_classificationReactive oxygen speciesElectron Transport Complex IInsulinMiddle Agedmedicine.diseaseMitochondriaOxygenOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2Glycated hemoglobinReactive Oxygen SpeciesOxidative stress
researchProduct

Inflammation et immunité : implications dans l’obésité et le diabète de type 2

2006

The evidences have been increasingly accumulated on the implication of inflammatory mediators like tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in the pathological states related to insulin resistance like obesity, type 2 diabetes and atherosclerosis. There seems a link between insulin resistance and these pro-inflammatory agents, secreted by macrophages and adipocytes. Th (helper) cells are differentiated into either Th1 or Th2 phenotypes. It is generally considered that Th1 phenotype is pro-inflammatory whereas Th2 phenotype exerts anti-inflammatory (protective) effects. The upregulation of Th1 phenotype may aggravate these pathologies. One of the adipokines, i.e., adiponectin…

medicine.medical_specialtyobesitymedicine.medical_treatmentPeroxisome proliferator-activated receptorInflammationlcsh:TP670-699BiologyBiochemistryPPARfatty acidsInsulin resistanceDownregulation and upregulationInternal medicinemedicinechemistry.chemical_classificationAdiponectinInsulinmedicine.diseaseInsulin receptorimmune systemEndocrinologyCytokinechemistryinflammationImmunologybiology.proteinmedicine.symptomlcsh:Oils fats and waxesFood ScienceOléagineux, Corps gras, Lipides
researchProduct

Effect of aerobic exercise on insulin resistance and central adiposity disappeared after the discontinuation of intervention in overweight women

2016

Purpose: This study aimed to assess whether the benefits of exercise on central adiposity and insulin resistance (HOMA-IR) are maintained after discontinuation of intervention in the overweight/obese (OWOB) women. Methods: The study subjects were from 2 independent studies with similar aerobic exercise (AE) intervention programs. In study I, 15 OWOB postmenopausal women with pre-diabetes (body mass index, BMI = 24–33 kg/m2 , aged 52–65 years) completed an 8-month exercise intervention and were followed for 2 years after the intervention. In study II, 12 OWOB (BMI = 25–35 kg/m2 , aged 30–50 years) premenopausal women participated in a 6-week AE and were followed for 4 years after the interve…

medicine.medical_specialtypremenopause030209 endocrinology & metabolismPhysical Therapy Sports Therapy and RehabilitationOverweight03 medical and health scienceslcsh:GV557-1198.9950302 clinical medicineInsulin resistanceIntervention (counseling)medicineAerobic exerciseta319Exercise interventionOrthopedics and Sports MedicineSpecial issue on "Physical activity continuum throughout the lifespan: is exercise a medicine or what?"030212 general & internal medicineObesityexercise interventionRelapselcsh:Sports medicineta315lcsh:SportsExercise interventionrelapsibusiness.industrynutritional and metabolic diseasesmedicine.diseaseObesityDiscontinuationPostmenopausepostmenopausePremenopausePhysical therapyCentral Adipositylihavuusmedicine.symptombusinesslcsh:RC1200-1245Journal of Sport and Health Science
researchProduct